Donald B. Kohn, M.d.

This early-phase study tested a gene therapy for adults with severe sickle cell disease. Doctors took the patients' own blood stem cells, added a working gene to help produce normal red blood cells, and infused them back. The goal was to see if the treatment is safe and could red…